Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers

Area of Science:

• Oncology
• Molecular Biology
• Gene Therapy

Background:

• Viral vector-mediated gene therapy is a promising cancer treatment strategy.
• Tumor suppressor genes like p53 and retinoblastoma (Rb) are commonly used but may not be effective for microsatellite instability-positive (MSI(+)) tumors.
• The RIZ1 gene is frequently mutated in MSI(+) cancers and induces cell cycle arrest and apoptosis.

Purpose of the Study:

• To investigate the therapeutic potential of RIZ1 gene expression in MSI(+) colorectal cancer.
• To compare the efficacy of RIZ1 gene therapy with p53 gene therapy in MSI(+) colorectal cancer models.

Main Methods:

• Adenovirus vectors were used for RIZ1 and p53 gene delivery.
• The study utilized MSI(+) HCT116 colorectal xenograft tumor models with RIZ1 mutations.
• Tumor growth suppression, cell transduction, and apoptosis induction were assessed.

Main Results:

• RIZ1 expression via adenovirus vectors suppressed the growth of MSI(+) HCT116 colorectal xenograft tumors.
• RIZ1 adenoviruses efficiently transduced malignant cells within established tumors, leading to apoptosis.
• A recombinant p53 adenovirus did not induce apoptosis or significant tumor suppression in this model.

Conclusions:

• RIZ1 gene therapy demonstrates significant potential for treating MSI(+) colorectal cancers.
• RIZ1 is a more effective therapeutic agent than p53 for MSI(+) colorectal tumors with RIZ1 mutations.
• RIZ1-mediated apoptosis offers a targeted approach for cancer gene therapy.